Leading Growth Driver in the Ventricular Assist Device Market in 2025: The Rising Prevalence Of Cardiovascular Disorders Propels Growth In Ventricular Assist Device Market Driver's Influence

What market dynamics are playing a key role in accelerating the growth of the ventricular assist device market?
The surge in occurrences of cardiovascular ailments is propelling the expansion of the ventricular assist device market. High blood pressure, smoking, high cholesterol, lack of physical activity, among others, cause these heart diseases. The rise in cardiovascular conditions can also be attributed to non-infectious diseases like diabetes, chronic respiratory diseases, and heart attacks resulting from hypertension. This substantial rise in cardiovascular diseases is likely to spur the need for ventricular assist devices, which serve as an indispensable support system for critically ill heart patients. For instance, the National Library of Medicine, a federal agency in the US, predicted in October 2022 that 45.1% of the US population is set to have cardiovascular disease by 2035. The overall expenditure related to cardiovascular diseases is anticipated to hit $1.1 trillion in 2035. Consequently, this increase in cardiovascular disease prevalence is likely to stimulate demand for ventricular assist devices in the forthcoming period.

Get Your Ventricular Assist Device Market Report Here:
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

How will the growth rate of the ventricular assist device market shape industry trends by 2034?
The size of the ventricular assist device market has experienced swift expansion in the recent past. Its growth is expected to continue from a $2.12 billion valuation in 2024, escalating to a $2.39 billion valuation in 2025, with a compound annual growth rate (CAGR) of 12.6%. The growth during the historical period was due to factors such as the rising incidence of heart failure and increased demand for organ transplantation procedures.

The market size for ventricular assist devices is predicted to experience a swift expansion in the forthcoming years, growing to a valuation of $3.91 billion by 2029 with a compound annual growth rate (CAGR) of 13.1%. Factors contributing to this growth over the forecast period include the growing demand for destination therapy, an aging demographic, the increase in healthcare spending, and heightened consciousness about heart failure treatments. Major market trends throughout the forecast period encompass extended focus on enhancing the useful life span of VADs, VAD miniaturization, advancements in pump technologies, a heightened emphasis on VAD safety and efficacy, reduction in VAD side effects, and the introduction of percutaneously inserted ventricular assist devices.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What are the most significant trends transforming the ventricular assist device market today?
The market is seeing a surge in the popularity of percutaneously inserted ventricular assist devices. These non-pulsatile axial flow pumps, placed across the aortic valve, pump blood from the left ventricle. This helps to alleviate the burden on the left ventricle and lowers myocardial oxygen consumption, enhancing cardiac output and decreasing left ventricular end-diastolic pressure. In August 2022, for instance, the US medical device firm, Abiomed Inc, launched its percutaneous VAD, Impella, for suitable pediatric patients in the USA. The device serves to adequately support cardiac function by offsetting a malfunctioning left ventricle in patients. Furthermore, it can operate as a replacement for extracorporeal membrane oxygenation (ECMO), or as a complementary therapy to better hemodynamics.

Which primary segments of the ventricular assist device market are driving growth and industry transformations?
The ventricular assist device market covered in this report is segmented -

1) By Product: Left Ventricular Assist Devices (LVADs), Right Ventricular Assist Devices (RVADs), Biventricular Assist Devices (BIVADs).
2) By Type: Pulsatile Flow, Continuous Flow
3) By Design: Transcutaneous Ventricular Assist Devices, Implantable Ventricular Assist Devices
4) By Application: Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Recovery (BTR) Therapy, Bridge-To-Candidacy (BTC) Therapy
5) By End Users: Hospital, Ambulatory Surgical Centres, Cardiology Centres

Subsegments:
1) By Left Ventricular Assist Devices (LVADs): Implantable LVADs, Temporary LVADs
2) By Right Ventricular Assist Devices (RVADs): Implantable RVADs, Temporary RVADs
3) By Biventricular Assist Devices (BIVADs): Full Support BIVADs, Hybrid BIVADs

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6680

Which geographical regions are pioneering growth in the ventricular assist device market?
North America was the largest region in the ventricular assist device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the influential players reshaping the ventricular assist device market landscape?
Major companies operating in the ventricular assist device market include Abiomed, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd, Huadong Medicine Co. Ltd, Shenzhen Hexin Zondan Medical Equipment Co. Ltd, Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc, Evaheart Inc, BiVACOR Inc, ReliantHeart Inc, Cardiac Assist Inc, Heart Ware International, Braile Biomedica Ltd

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=6680&type=smp

What Is Covered In The Ventricular Assist Device Global Market Report?

• Market Size Forecast: Examine the ventricular assist device market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the ventricular assist device market for a structured understanding.
• Key Players Overview: Analyze major players in the ventricular assist device market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the ventricular assist device market.
• Segment Contributions: Evaluate how different segments drive overall growth in the ventricular assist device market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the ventricular assist device market.
• Industry Challenges: Identify potential risks and obstacles affecting the ventricular assist device market.
• Competitive Landscape: Review strategic developments in the ventricular assist device market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.